• SENSEX 77,250.10
    332.25 (+0.43%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • Reliance Industries
    1,315.50 1,611.20(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    647.20 574.85(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Aster DM Quality
    710.25 890.95(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • Jio Platforms
    1,420.50 1,356.40(%)
  • SFC Enviro.
    397.60 354.05(%)
  • Global Health
    1,422.10 1,542.00(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • BLS Polymers
    261.80 225.00(%)
  • J K Cements
    5,155.30 6,363.00(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • ITC
    283.50 421.70(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,942.00 3,840.00(%)
  • TBO Tek
    1,522.00 1,005.50(%)
  • Fractal Analyt.
    839.45 1,119.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cohance Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74679.0
  • ISIN : INE03QK01018
440.35 -7 (-1.50%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    438.50

  • Today’s High

    453.15

  • Open

    450.00

  • Perv Close

    447.05

  • 52W Low

    266.70

  • 52W High

    760.80

Key Indicators

  • P/E(TTM)

    88.03

  • Mar.Cap (₹Cr.)

    16,847.67

  • Div & Yield %

    0.00

  • Book Value(₹)

    117.10

  • Debt-Equity Ratio

    -1.50

  • AGM Date

    03-Nov-2026

  • EPS

    5.00

  • P/E Ratio

    88.03

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    16,847.67

  • RONW (%)

    14.11

  • ROCE (%)

    18.69

Score Board

  • Equity (₹ in Cr.)

    38.26

  • BV (₹)

    117.10

  • Sales( ₹ in Cr.)

    2,030.50

  • NP (in Cr.)

    249.38

  • NP Var(%)

    -50.0

  • Div%

    0.0

  • CPS (₹)

    10.00

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    16,840.02

  • 52 Week High

    760.80

  • 52 Week Low

    266.70

  • Price BSE

    440.0

  • Price NSE

    440.00

  • Market Capital( in Cr.)

    16,840.02

  • P/C Ratio

    44.00

  • P/E Ratio

    67.50

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,030.50 2,504.43 1,051.35 1,330.08 1,320.22 1,009.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,030.50 2,504.43 1,051.35 1,330.08 1,320.22 1,009.72
Other Income 44.73 64.84 56.61 44.55 187.79 14.24
Stock Adjustments 38.58 -110.32 -49.16 20.94 60.35 8.37
Total Income 2,113.81 2,458.95 1,058.80 1,395.57 1,568.36 1,032.33
EXPENDITURE :            
Raw Materials 691.27 699.91 265.88 421.36 459.46 310.32
Power and Fuel Cost 109.60 102.39 48.30 71.35 59.55 44.20
Employee Cost 380.43 396.55 135.23 108.58 100.48 76.23
Other Manufacturing Expenses 213.69 195.14 88.31 101.96 115.25 90.76
Selling and Administration Expenses 180.05 159.61 37.51 43.57 52.38 44.93
Miscellaneous Expenses 69.10 72.08 21.10 13.50 11.17 8.61
Employee Benefit Expenses 380.43 396.55 135.23 108.58 100.48 76.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,644.14 1,625.68 596.33 760.33 798.29 575.05
Operating Profit 469.67 833.27 462.47 635.24 770.08 457.28
Interest 22.46 36.70 7.45 12.75 8.53 11.66
Gross Profit 447.21 796.57 455.02 622.49 761.55 445.62
Depreciation 133.58 146.51 54.60 43.10 39.10 31.64
Profit Before Tax 313.63 650.06 400.42 579.39 722.45 413.98
Current Tax 78.10 171.31 97.36 142.45 157.63 101.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.82 -12.43 6.59 4.34 6.72 3.62
Reported Net Profit 228.71 491.18 296.47 432.60 558.10 308.65
Extraordinary Items -20.67 -11.72 -0.05 10.55 14.53 2.51
Adjusted Net Profit 249.38 502.90 296.52 422.05 543.57 306.14
Adjustment below Net Profit 1.53 0.33 -0.32 -0.26 -0.76 -0.84
P & L Balance brought forward 2,739.59 2,248.08 1,470.91 1,276.39 835.88 568.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 218.65 116.83 40.46
P & L Balance carried down 2,969.83 2,739.59 1,767.06 1,490.07 1,276.39 835.88
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 600.00 500.00 200.00
Dividend Per Share(Rs) 0.00 0.00 0.00 6.00 5.00 2.00
Earnings Per Share-Unit Curr 5.98 19.29 11.64 16.99 21.92 12.12
Earnings Per Share(Adj)-Unit Curr 5.98 19.29 11.64 16.99 21.92 12.12
Book Value 117.10 166.88 79.67 68.72 59.74 41.84
Book Value(Adj)-Unit Curr 117.10 166.88 79.67 68.72 59.74 41.84

Shareholding Pattern

  • Promoter Group

    57.48%

  • Public Share Holding

    42.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 219,930,170 57.48 219,930,170 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 219,930,170 57.48 219,930,170 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 211 0.00 211 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 29,484,702 7.71 29,484,702 97
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,792,776 1.78 6,792,776 3
Mutual Funds / UTI 64,782,816 16.93 64,746,816 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 578,851 0.15 578,851 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 101,639,356 26.57 101,603,356 137
2] Non Institution
Bodies Corporate 28,800,839 7.53 28,796,839 593
Clearing Members 30 0.00 30 1
Directors of their Relatives 118 0.00 118 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,112,510 0.55 2,112,510 2,320
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 979,131 0.26 978,631 1,637
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 930,499 0.24 930,499 3
Individuals holding nominal share capital up to Rs. 1 lakh 27,747,119 7.25 27,471,057 89,143
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,629 0.00 2,629 7
Others 420,023 0.11 420,023 1
Sub Total 61,027,804 15.95 60,747,242 93,707
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 382,597,330 100.00 382,280,768 93,846

Company Background

Cohance Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cohance Lifesciences Ltd
  • BSE Code : 74679.0
  • ISIN : INE03QK01018

  • Incorporation Year

    2018

  • Registered Office

    8-2-334 SDE Serene Chambers
    3 Floor Avenue 7 Road No 5, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23549414/1142/3311

  • FAX

    91-40-23541152

  • Chairman

    Umang Vohra

  • Managing Director

  • Company Secretary

    S. K. Mishra

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Cohance Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cohance Life 440.15 2,075.23 2,030.50 94.86 7.31
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77